ZEALAND PHARMA A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 622 DKK | +3.84% |
|
+6.60% | +66.67% |
| 04-04 | U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year | DJ |
| 03-20 | Zealand Pharma A/S Approves Appointments to the Board | CI |
Evolution of the average Target Price on Zealand Pharma A/S
Price target over the last 5 years
History of analyst recommendation changes
e752f9f3072fd498e.ENZjQwHJa85bVa7yArsvt2KYwcQtgs1rB1PjzkyM-7E.fOAyCGSrOpEXE-O3N8IYhFTdlLBlxKwpVB_SjWH1kIUmmBZ1arhc9mMA-w~4e0d3d92e6a801fa8cc37d30b12e4a50
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
622
DKK
Average target price
782
DKK
Spread / Average Target
+25.72%
High Price Target
840
DKK
Spread / Highest target
+35.05%
Low Price Target
600
DKK
Spread / Lowest Target
-3.54%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Zealand Pharma A/S
| Goldman Sachs |
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- ZEAL Stock
- Consensus Zealand Pharma A/S
